WPI 3171 (Alendronate 35 mg)

Pill imprint WPI 3171 has been identified as Alendronate sodium 35 mg.

Alendronate is used in the treatment of osteoporosis; prevention of osteoporosis; paget's disease; aseptic necrosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Alendronate 35 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for WPI 3171 (Alendronate 35 mg)

Alendronate sodium 35 mg WPI 3171
Alendronate sodium 35 mg WPI 3171
Alendronate sodium
Imprint:
WPI
3171
Strength:
35 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Bisphosphonates
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
00591-3171
Inactive Ingredients:
magnesium stearate
mannitol
microcrystalline cellulose
sodium starch glycolate type A potato
corn starch
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
21695-0901 Rebel Distributors Corp (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Suffering from sore knees? Assess your knee pain with our interactive tool. Click Here

Close
Hide
(web5)